You have read all your free articles, to continue reading subscribe to read the rest of this content.
InDex Pharmaceuticals Holding announces that a new method of use patent for the drug candidate cobitolimod will be issued by the United States Patent and Trademark Office (USPTO). The patent provides additional protection for treating chronic active ulcerative colitis in patients that are not resAlready a subscriber Login You have…
Nordic Nanovector has announced the grant of an EU patent covering the use of Alpha37 for the treatment of Chronic Lymphocytic Leukemia (CLL) and non-Hodgkin’s lymphoma (NHL). Alpha37 is an investigational radioimmunoconjugate developed by Nordic Nanovector in collaboration with Orano Med comprAlready a subscriber Login You have read all your…
The United States Patent and Trademark Office (USPTO) has granted the company's patent application directed to gluconic acid derivatives for preventing and/or treating bacterial infections. “The US patent covering treatment and prevention of vaginal bacterial infections by GDL, or pHyph, strengAlready a subscriber Login You have read all your free…
Lobsor Pharmaceuticals has announced the Japanese Patent Office has issued a Decision to Grant a patent covering Lecigon a new therapeutic system for symptomatic treatment of Advanced Parkinson’s Disease (APD). Lecigon is a proprietary pharmaceutical gel formulation containing a combination of Already a subscriber Login You have read all your…
